Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Nov. 22, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming investor conferences: The Nasdaq 47 th Investor
View HTML
Toggle Summary Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
ACTON, Mass. --(BUSINESS WIRE)--Nov. 14, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable.
View HTML
Toggle Summary Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), announced on October 17, 2022 , a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers (PDMs) distributed globally. This action was taken voluntarily with the knowledge
View HTML
Toggle Summary Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency¹)
ACTON, Mass. --(BUSINESS WIRE)--Nov. 3, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2022 .
View HTML
Toggle Summary Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
ACTON, Mass. --(BUSINESS WIRE)--Nov. 1, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced a variety of educational campaigns and activities in recognition of National
View HTML
Toggle Summary Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
ACTON, Mass. --(BUSINESS WIRE)--Sep. 22, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the third quarter of 2022 on November
View HTML
Toggle Summary Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
ACTON, Mass. --(BUSINESS WIRE)--Sep. 20, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has received CE marking under the European Medical Device Regulation for its
View HTML
Toggle Summary Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
Omnipod 5 is the first tubeless AID System cleared in the U.S. for preschool children ACTON, Mass. --(BUSINESS WIRE)--Aug. 22, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Aug. 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at four upcoming investor conferences (all Eastern Time): The
View HTML
Toggle Summary Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency¹)
Recently Launched U.S. Full Market Release for Omnipod ® 5 - Now Available through Retail Pharmacies ACTON, Mass. --(BUSINESS WIRE)--Aug. 4, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of
View HTML
Toggle Summary Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
Omnipod 5 is Now Fully Available through Retail Pharmacy Channels ACTON, Mass. --(BUSINESS WIRE)--Aug. 1, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its Omnipod ® 5
View HTML
Toggle Summary Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
ACTON, Mass. --(BUSINESS WIRE)--Jun. 30, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the second quarter of 2022 on August
View HTML
Toggle Summary Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years
Insulet Presents Pivotal Extension Data for Preschool Children and Other Omnipod® 5 System Clinical Research at American Diabetes Association 82 nd Scientific Sessions ACTON, Mass. --(BUSINESS WIRE)--Jun. 3, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
View HTML
Toggle Summary Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference
ACTON, Mass. --(BUSINESS WIRE)--Jun. 2, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the William Blair & Company 42 nd Annual Growth Stock Conference
View HTML
Toggle Summary Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia
ACTON, Mass. --(BUSINESS WIRE)--Jun. 1, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host a groundbreaking ceremony for its new manufacturing facility in Malaysia , further
View HTML